TuesdayOct 18, 2022 2:09 pm

TinyGemsBreaks – Knightscope Inc. (NASDAQ: KSCP) Innovative Robot Roadshow Makes Stop in Dallas

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”), and its Robot Roadshow are spending the day in Dallas. The roadshow is a free, engaging experiential event that is designed to provide potential clients, media and investors with an opportunity to see Knightscope’s game-changing security robots up close and personal. The stop in Dallas is at the Commemorative Air Force location from 10 a.m. to 3 p.m. CT. Knightscope is committed to share its offerings through creative marketing events, and the roadshow is an ideal example of this. So far, the event has landed in 64 different locations…

Continue Reading

TuesdayOct 18, 2022 1:34 pm

TinyGemsBreaks – Cepton Inc. (NASDAQ: CPTN) Schedules Release of Q3 2022 Results, Conference Call

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, has announced that it will provide a business update and release its financial results for the third quarter of 2022 following the close of the market on Tuesday, Nov. 8, 2022. In addition, Cepton will hold a conference call and webcast at 2:30 p.m. PT (5:30 p.m. ET) that same day. Interested parties may join the call by dialing 888-999-6281 and visiting https://ibn.fm/01a5B for the live webcast. A replay will be available approximately two hours after the live call and until Nov. 22, 2022, and can be…

Continue Reading

TuesdayOct 18, 2022 12:59 pm

TinyGemsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Announces Agreement with Columbia University to Extend Research Pact

Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, has entered into an agreement with Columbia University to extend its current research partnership efforts. The agreement outlines certain assets that are currently under development regarding the work of associate professor of clinical Neurobiology Dr. Christine Ann Denny at Columbia University Irving Medical Center. Denny and her team are studying the molecular mechanisms underlying learning and memory, including diseases such as Alzheimer’s disease. According to the announcement, Denny’s pioneering research is evaluating whether ketamine and novel inventions associated with the substance have potential…

Continue Reading

MondayOct 17, 2022 11:24 am

TinyGemsBreaks — Cepton Technologies Inc. (NASDAQ: CPTN) Partners with LidarSwiss to Create Nano P60 System

Cepton Technologies (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, announced that LidarSwiss Solutions GmbH is deploying its Sora(TM) lidar technology in the company’s drone-based mapping and analytics solution, which is available for infrastructure management and engineering design applications. The full Nano P60 system is on display at the INTERGEO event, held Oct. 18–20, 2022, in Germany. Based in Switzerland, LidarSwiss provides high-performance unmanned aerial vehicle (“UAV”)-based lidar solutions that feature high-fidelity mapping and real-time processing, a key solution for engineers, forestry managers and urban planners. The Nano P60 platform has been used to map and analyze…

Continue Reading

FridayOct 14, 2022 10:31 am

TinyGemsBreaks — Cepton Technologies Inc. (NASDAQ: CPTN) Nova Lidar Earns AutoTech Breakthrough Top Honor

Cepton Technologies (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, was recognized for its Nova Lidar sensor in the third annual AutoTech Breakthrough Awards program. A miniature, near-range lidar sensor designed to enhance vehicle safety and enable autonomous driving capabilities, Nova Lidar was named Automotive Sensor Hardware Solution of the year by AutoTech Breakthrough. The leading market intelligence organization annually recognizes top companies, technologies and products throughout the global automotive and transportation technology markets. Other companies that were awarded top awards for their advancements in automotive and transportation technologies included BMW, Toyota and Lyft. Nova Lidar can…

Continue Reading

ThursdayOct 13, 2022 1:45 pm

TinyGemsBreaks – Knightscope Inc. (NASDAQ: KSCP) Robot Show Takes the Spotlight in Lebanon, Ohio

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, most recently hosted its Robot Roadshow at Miami Valley Gaming in Lebanon, Ohio, on Oct. 12, 2022. The Robot Roadshow is an engaging experiential event designed to grab attention, forge direct connections with potential clients, and strike up conversations in a compelling fashion. The announcement from yesterday reads, “The Robot Roadshow has made 63 landings in 23 states and Washington, D.C., to date. Knightscope’s crime-fighting robots tour the U.S. in a space-age, NASA-like ‘pod’ allowing attendees to experience all the technology that is enabling…

Continue Reading

WednesdayOct 12, 2022 4:01 pm

TinyGemsBreaks – Knightscope Inc. (NASDAQ: KSCP) Signs Acquisition Deal; CEO Featured in Leadership Interview

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots, announced that it has entered a definitive agreement for the acquisition of CASE Emergency Systems. The transaction is expected to close later this month. According to the announcement, Knightscope is making the strategic move to boost revenues and expand its ability to make a positive impact on the safety of communities nationwide. A leader in blue-light emergency phones and an innovator in next-generation wireless emergency communications technology, CASE gives Knightscope a strategic entry into a nationwide market. Last year, CASE reported profitable revenue of more than $5.4 million. The planned…

Continue Reading

WednesdayOct 12, 2022 12:17 pm

TinyGemsBreaks – Aditxt Inc. (NASDAQ: ADTX) Announces Publication of Innovative Mathematical Model

Aditxt (NASDAQ: ADTX), a biotech innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced publication of a mathematical model for predicting the durability and rate of decay of neutralizing antibodies to SARS-CoV-2 in a peer-reviewed research paper in the Journal of Theoretical Biology. The publication, titled “A mathematical model of the within-host kinetics of SARS-CoV-2 neutralizing antibodies following COVID-19 vaccination,” describes a model developed with Dr. Lisette de Pillis, a professor of life sciences and mathematics at Harvey Mudd College. NAb inhibit viral binding to the human cell receptor thereby reducing…

Continue Reading

TuesdayOct 11, 2022 11:24 am

TinyGemsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), The Chopra Foundation Note World Mental Health Day

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), joined partner The Chopra Foundation in recognizing World Mental Health Day, which was Monday, Oct. 11, 2022. The two organizations are working together to research the potential of psychedelic-based therapies for the treatment of mental health and to provide education about the use of psychedelics. Founded by Dr. Deepak Chopra, The Chopra Foundation is a not-for-profit organization dedicated to improving health and well-being. World Mental Health Day was designed to create an opportunity for those with mental health issues, along with advocates, governments, employers, employees and…

Continue Reading

MondayOct 10, 2022 11:58 am

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Participate in Breakthrough for Brain Tumors(R) 5K Run

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that its Chief Executive Officer John Climaco will participate in The American Brain Tumor Association’s Breakthrough for Brain Tumors(R) 5K Run. The event is taking place on Saturday, Nov. 5, 2022, in Los Angeles, California. “The unmet need in brain tumor treatment is immense and knows no geographic borders. As CEO of CNS, I have come to know many brain tumor patients personally and the optimism and strength with which they have…

Continue Reading

Contact us: (512) 354-7000